GB1323842A - Immunizing vaccine for the immunization of dogs against kennel cough - Google Patents

Immunizing vaccine for the immunization of dogs against kennel cough

Info

Publication number
GB1323842A
GB1323842A GB5524971A GB5524971A GB1323842A GB 1323842 A GB1323842 A GB 1323842A GB 5524971 A GB5524971 A GB 5524971A GB 5524971 A GB5524971 A GB 5524971A GB 1323842 A GB1323842 A GB 1323842A
Authority
GB
United Kingdom
Prior art keywords
vaccine
immunization
kennel cough
dogs
dogs against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5524971A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Veterinary Inc
Original Assignee
Pitman Moore Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pitman Moore Inc filed Critical Pitman Moore Inc
Publication of GB1323842A publication Critical patent/GB1323842A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1323842 Vaccine for dogs PITMANMOORE Inc 29 Nov 1971 [2 Dec 1970] 55249/71 Heading A5B A vaccine for the immunization of dogs against kennel cough comprises an effective immunizing amount of live, non-pathogenic, canine parainfluenza virus and live, non- pathogenic, canine adenovirus Type 2, in a physiologically acceptable carrier. The vaccine may also contain inactivated Bordetella bronchisepticus bacteria. Stabilizers such as dextrose and lactose may also be present and the product may be desiccated, e.g. by freeze drying, for storage purposes.
GB5524971A 1970-12-02 1971-11-29 Immunizing vaccine for the immunization of dogs against kennel cough Expired GB1323842A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9457070A 1970-12-02 1970-12-02

Publications (1)

Publication Number Publication Date
GB1323842A true GB1323842A (en) 1973-07-18

Family

ID=22245948

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5524971A Expired GB1323842A (en) 1970-12-02 1971-11-29 Immunizing vaccine for the immunization of dogs against kennel cough

Country Status (4)

Country Link
JP (1) JPS5547012B1 (en)
AU (1) AU452255B2 (en)
CA (2) CA954792A (en)
GB (1) GB1323842A (en)

Also Published As

Publication number Publication date
CA954792A (en) 1974-09-17
AU3635271A (en) 1973-06-07
AU452255B2 (en) 1974-08-29
CA999523B (en) 1976-11-09
JPS5547012B1 (en) 1980-11-27

Similar Documents

Publication Publication Date Title
GB1439407A (en) Method for preventing respiratory mycoplasmosis of livestock
ES375448A1 (en) 1-phenoxy-2-hydroxy-3-alkylamino-propanes
GB1059676A (en) Process for stabilising biologically active proteinaceous materials
ES426215A1 (en) Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
GB1292803A (en) Improvements relating to the production of antigens
GB1323842A (en) Immunizing vaccine for the immunization of dogs against kennel cough
GB1399782A (en) Vaccines for immunization against kennel cough
GB1375866A (en)
FR1605222A (en) Vaccine against salmonella choleraesuis infection
GB1016586A (en) Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis
GB1152607A (en) Antigenic Compositions
GB1234747A (en) Improvements in or relating to the protection of domestic animals against pathogenic organisms
GB1481650A (en) Chemical processes and products
GB1085798A (en) Vaccine for combating salmonella infections
GB949400A (en) Poliomyelitis vaccines
ES482549A0 (en) A METHOD FOR THE PREPARATION OF A HERPES VIRUS COMPOSITION
FR2174745A1 (en) Mixed veterinary vaccine - active against symptomatic and bacterial anthrax
GB1091595A (en) Brucella vaccines
GB1439742A (en) Live influenza type b virus vaccines and preparation thereof
GB1199251A (en) Cultivating Foot and Mouth Disease Virus
BE757336A (en) 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors
ES371256A1 (en) A procedure for the preparation of a multivalent vaccine. (Machine-translation by Google Translate, not legally binding)
ES224455A1 (en) Procedure for the preparation of tissue tropism vaccines (Machine-translation by Google Translate, not legally binding)
GB1065875A (en) Measles vaccine attenuated through avian choric-allantoic membrane
FR2143572A1 (en) Rubella vaccine - highly attenuated live form, free from side effects

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years